Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes. Kosiborod MN, Petrie MC, Borlaug BA, Butler J, et al. N Engl J Med 2024 Apr 6. doi: 10.1056/NEJMoa2313917.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kosiborod MN, Petrie MC, Borlaug BA, Butler J, et al. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes. N Engl J Med 2024 Apr 6. doi: 10.1056/NEJMoa2313917.
PMID: 38587233